• Article

Budget Impact of Adding Delayed-Release Dimethyl Fumarate to the Formulary for the Treatment of Relapsing Forms of Multiple Sclerosis

Bibliography

Mauskopf, J., Fay, M., Iyer, R., & Livingston, T. (2014). Budget Impact of Adding Delayed-Release Dimethyl Fumarate to the Formulary for the Treatment of Relapsing Forms of Multiple Sclerosis. Value in Health, 17(3), A58-A58.